Literature DB >> 27064296

Understanding, preventing and eradicating Klebsiella pneumoniae biofilms.

Suzana Meira Ribeiro1,2, Marlon Henrique Cardoso1,2,3, Elizabete de Souza Cândido1,2, Octávio Luiz Franco1,2,3.   

Abstract

The ability of pathogenic bacteria to aggregate and form biofilm represents a great problem for public health, since they present extracellular components that encase these micro-organisms, making them more resistant to antibiotics and host immune attack. This may become worse when antibiotic-resistant bacterial strains form biofilms. However, antibiofilm screens with different compounds may reveal potential therapies to prevent/treat biofilm infections. Here, we focused on Klebsiella pneumoniae, an opportunistic bacterium that causes different types of infections, including in the bloodstream, meninges, lungs, urinary system and at surgical sites. We also highlight aspects involved in the formation and maintenance of K. pneumoniae biofilms, as well as resistance and the emergence of new trends to combat this health challenge.

Entities:  

Keywords:  Klebsiella pneumonia; antibiofilm agents; bacterial resistance; biofilm; infections

Mesh:

Year:  2016        PMID: 27064296     DOI: 10.2217/fmb.16.7

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  6 in total

1.  The Membranotropic Peptide gH625 to Combat Mixed Candida albicans/Klebsiella pneumoniae Biofilm: Correlation between In Vitro Anti-Biofilm Activity and In Vivo Antimicrobial Protection.

Authors:  Angela Maione; Elisabetta de Alteriis; Federica Carraturo; Stefania Galdiero; Annarita Falanga; Marco Guida; Anna Di Cosmo; Valeria Maselli; Emilia Galdiero
Journal:  J Fungi (Basel)       Date:  2021-01-05

2.  Biofilm Production by Carbapenem-Resistant Klebsiella pneumoniae Significantly Increases the Risk of Death in Oncological Patients.

Authors:  Enea Gino Di Domenico; Ilaria Cavallo; Francesca Sivori; Francesco Marchesi; Grazia Prignano; Fulvia Pimpinelli; Isabella Sperduti; Lorella Pelagalli; Fabiola Di Salvo; Ilaria Celesti; Silvia Paluzzi; Carmelina Pronesti; Tatiana Koudriavtseva; Fiorentina Ascenzioni; Luigi Toma; Assunta De Luca; Andrea Mengarelli; Fabrizio Ensoli
Journal:  Front Cell Infect Microbiol       Date:  2020-12-10       Impact factor: 5.293

3.  The Role of ZntA in Klebsiella pneumoniae Zinc Homeostasis.

Authors:  Eve A Maunders; Katherine Ganio; Andrew J Hayes; Stephanie L Neville; Mark R Davies; Richard A Strugnell; Christopher A McDevitt; Aimee Tan
Journal:  Microbiol Spectr       Date:  2022-01-12

4.  The Mutation in wbaP cps Gene Cluster Selected by Phage-Borne Depolymerase Abolishes Capsule Production and Diminishes the Virulence of Klebsiella pneumoniae.

Authors:  Marta Kaszowska; Grazyna Majkowska-Skrobek; Pawel Markwitz; Cédric Lood; Wojciech Jachymek; Anna Maciejewska; Jolanta Lukasiewicz; Zuzanna Drulis-Kawa
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

5.  Bactericidal, anti-biofilm, and anti-virulence activity of vitamin C against carbapenem-resistant hypervirulent Klebsiella pneumoniae.

Authors:  Chen Xu; Ning Dong; Kaichao Chen; Xuemei Yang; Ping Zeng; Changshun Hou; Edward Wai Chi Chan; Xi Yao; Sheng Chen
Journal:  iScience       Date:  2022-02-08

6.  Characterization and Full Genome Sequence of Novel KPP-5 Lytic Phage against Klebsiella pneumoniae Responsible for Recalcitrant Infection.

Authors:  Ahmed R Sofy; Noha K El-Dougdoug; Ehab E Refaey; Rehab A Dawoud; Ahmed A Hmed
Journal:  Biomedicines       Date:  2021-03-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.